Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Genisphere, MultiCell Technologies deal

The companies partnered to evaluate the use of Genisphere's 3DNA Dendrimer nanoparticle drug delivery

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE